Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.

ABSTRACT: This is a multicenter, open label, phase II trial to determine the safety, tolerability, and immunogenicity and initial clinical activity of the combination treatment of PolyPEPI1018 vaccine and atezolizumab in participants with MSS CRC who have progressed on 2 or 3 prior regimens.

DISEASE(S): Colorectal Neoplasms,Colorectal Cancer Metastatic

PROVIDER: 2404990 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR